Iterum Therapeutics | 8-K: Iterum Therapeutics Reports Second Quarter 2024 Financial Results
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
07:32
The Nikkei/Yen Futures opened up 295 points at the Singapore Exchange, reporting at 38,755 points.
07:30
Institutions: Apple and Samsung experienced a decline in smart phone shipments in the fourth quarter.
AAPL-1.03%
07:26
China Pacific Insurance received a Shareholding of 1.2257 million shares from JPMorgan.
China Pacific Insurance-1.86%